Ofatumumab is a monoclonal antibody that is used in the treatment of certain types of blood cancers, such as chronic lymphocytic leukemia (CLL) and follicular lymphoma. It works by targeting a specific protein on the surface of cancer cells, which helps to slow down the growth and spread of the cancer.
This drug is typically given as an infusion in a medical setting, and the frequency and dosage will depend on the specific type of cancer being treated. It is important to follow your healthcare provider’s instructions carefully and attend all scheduled appointments to ensure the best possible outcome.
Like all medications, Ofatumumab can cause side effects. Some common side effects may include infusion reactions, low blood cell counts, and increased risk of infections. It is important to report any side effects to your healthcare provider so they can be properly managed.
Before starting treatment with Ofatumumab, it is important to discuss your medical history and any other medications or supplements you are taking with your healthcare provider. They will be able to determine if this drug is the right choice for you and monitor your progress throughout treatment.
Overall, Ofatumumab can be an effective treatment option for certain types of blood cancers. By working closely with your healthcare team and following their guidance, you can help manage your condition and improve your quality of life.